Use of unique animal models to study reversible effects of hyperglycaemia on the arterial edothelium in vivo. (360G-Wellcome-077683_Z_05_Z)
Despite many noteworthy achievements in management, most individuals with diabetes will still die early largely as a result of arterial diseases and heart attacks. In fact, likelihood of developing coronary disease rises by 300% or more if you develop diabetes and is more likely to prove fatal. Surprisingly, given that high blood glucose levels are the 'hallmark' feature of diabetes, we still do not fully understand how glucose itself might damage the arteries and cause heart attacks. In order to understand heart artery diseases in diabetes we must disentangle the effects of glucose from those of high blood fats, blood pressure etc. Since this is not currently possible in man we will use uniquely appropriate mouse models to answer the following critical questions:a) Does high glucose change the proteins being made in the artery wall or the types of cells that are present and over what time?b) Can these changes go back to normal if we set the glucose level back to normal?c) Do the above changes effect the development of fatty deposits that cause heartattacks? Understanding these processes will greatly increase our understandingof coronary diseases in diabetes and might help identify new targets for future drug development.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 177335 |
Applicant Surname | Khan |
Approval Committee | Physiological Sciences Funding Committee |
Award Date | 2005-11-07T00:00:00+00:00 |
Financial Year | 2005/06 |
Grant Programme: Title | Project Grant |
Internal ID | 077683/Z/05/Z |
Lead Applicant | Dr Michael Khan |
Other Applicant(s) | Prof David Epstein |
Partnership Value | 177335 |
Planned Dates: End Date | 2009-01-31T00:00:00+00:00 |
Planned Dates: Start Date | 2006-02-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | West Midlands |